Table I.

Patient characteristics.

	No. (%) (n=81)	miRNA-126
		Median (95% CI)	p-value
Gender			0.04
Male	37 (46)	1.00 (0.87–1.28)
Female	44 (54)	0.83 (0.59–1.08)
Age (years)			0.09
Mean (SD)	71.7 (11.1)
Range	47–91
>mean	44 (54)	0.85 (0.89–1.48)
<mean	37 (46)	1.02 (0.89–1.48)
T category			0.72
1–3	63 (78)	0.97 (0.82–1.12)
4	18 (22)	0.79 (0.59–1.48)
N category			0.81
0	46 (57)	0.99 (0.72–1.13)
1–2	35 (43)	0.96 (0.77–1.28)
M category			0.57
0	65 (80)	0.96 (0.81–1.12)
1	16 (20)	0.90 (0.70–1.69)
Stage			0.73
I–II	43 (53)	1.01 (0.68–1.13)
III–IV	38 (47)	0.95 (0.77–1.28)
Localisation
Rectum	20 (25)	0.88 (0.70–1.48)	0.88
Colon	61 (75)	0.98 (0.77–1.23)	0.07
Left colon	28 (46)	1.05 (0.94–1.47)
Right colon	33 (54)	0.77 (0.56–1.13)
MSI status			0.33
MSI	15 (19)	0.72 (0.38–1.24)
MSS	66 (81)	0.96 (0.82–1.08)
Tumour grade			0.74
1 and 2	61 (75)	0.95 (0.79–1.08)
3	20 (25)	0.96 (0.59–1.58)
Vascular invasion			0.42
Yes	10 (12)	1.08 (0.70–1.73)
No	71 (88)	0.96 (0.79–1.02)
Neuronal invasion			0.18
Yes	10 (12)	1.32 (0.70–1.87)
No	71 (88)	0.94 (0.77–1.02)
Peritoneal perforation			0.33
Yes	17 (21)	0.77 (0.59–1.36)
No	64 (79)	0.97 (0.83–1.12)

CI, confidence interval; SD, standard deviation; MSI, microsatellite instable; MSS, microsatellite stable.